OrbiMed Capital GP VII LLC — SEC insider filings

SEC reporting owner CIK 1760648. 73 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers the 50 most recent of 73 filings on record, filed 2022-05-05 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)10% owner5—8 legs · 2,174,831 sh · $74,560,2964
Electra Therapeutics, Inc. (ETRA)Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
ADARx Pharmaceuticals, Inc. (ADRX)Director, 10% owner23 legs · 950,000 sh · $16,150,000—16
Q32 Bio Inc. (QTTB)Director, 10% owner12 legs · 1,875,000 sh · $15,000,000——
Aspen Neuroscience, Inc. (ASPE)Director, 10% owner21 leg · 1,000,000 sh · $15,000,000—10
MBX Biosciences, Inc. (MBX)Director, 10% owner26 legs · 940,672 sh · $14,020,756—5
Keros Therapeutics, Inc. (KROS)Director2—2 legs · 250,000 sh · $11,002,5002
Terns Pharmaceuticals, Inc. (TERN)Director, 10% owner34 legs · 3,827,931 sh · $9,929,8006 legs · 56,164 sh · $561,6403
Kinnate Biopharma Inc. (KNTE)Director, 10% owner414 legs · 2,866,100 sh · $7,760,135—7
Arcutis Biotherapeutics, Inc. (ARQT)10% owner1—2 legs · 341,971 sh · $7,287,402—

+6 more issuers among the filings shown — every filing appears in the table below.

Insider filings — OrbiMed Capital GP VII LLC

FiledFormIssuerReported transactionsSource
2026-11-104Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-054Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-11-044Aspen Neuroscience, Inc. (ASPE)
jointly with ORBIMED ADVISORS LLC
Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 moreEDGAR
2026-10-293Aspen Neuroscience, Inc. (ASPE)
jointly with ORBIMED ADVISORS LLC
Holdings only — no transactions reportedEDGAR
2026-09-304ADARx Pharmaceuticals, Inc. (ADRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Genesis GP LLC
Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 moreEDGAR
2026-09-243ADARx Pharmaceuticals, Inc. (ADRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Holdings only — no transactions reportedEDGAR
2026-09-234Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Conversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-06-244Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Sale (S): 24,846 @ $45.38 · Sale (S): 1,477 @ $45 · Sale (S): 787,024 @ $45.38 · Sale (S): 46,776 @ $45EDGAR
2026-06-174Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Sale (S): 9,086 @ $45.02 · Sale (S): 272,322 @ $45.02EDGAR
2026-06-014Q32 Bio Inc. (QTTB)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 1,250,000 @ $8 · Purchase (P): 625,000 @ $8EDGAR
2025-12-184Keros Therapeutics, Inc. (KROS)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Disposition to issuer (D): 140,057 @ $17.75 · Disposition to issuer (D): 74,465 @ $17.75EDGAR
2025-06-264Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 231,600 @ $0.35 · Sale (S): 138,800 @ $0.33 · Sale (S): 213,257 @ $0.33EDGAR
2025-04-244Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 78,049 @ $0.34 · Sale (S): 89,328 @ $0.34 · Sale (S): 68,195 @ $0.32EDGAR
2025-04-174Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 10,326 @ $0.38 · Sale (S): 61,638 @ $0.33 · Sale (S): 77,090 @ $0.33EDGAR
2025-02-194MBX Biosciences, Inc. (MBX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 17,962 @ $9.90 · Purchase (P): 29,540 @ $9.85 · Purchase (P): 49,070 @ $10.84 · Purchase (P): 94,100 @ $10.84EDGAR
2025-01-144Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 126,209 @ $0.66 · Sale (S): 17,986 @ $0.64 · Sale (S): 79,024 @ $0.60EDGAR
2025-01-084Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 19,481 @ $0.77 · Sale (S): 52,536 @ $0.71 · Sale (S): 75,007 @ $0.68EDGAR
2024-12-264Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 230,321 @ $0.60EDGAR
2024-12-114Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 54,181 @ $0.84 · Sale (S): 8,015 @ $0.80 · Sale (S): 80 @ $0.80EDGAR
2024-12-064Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 76,200 @ $0.79 · Sale (S): 20,903 @ $0.82EDGAR
2024-11-054Lomond Therapeutics Holdings, Inc.
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Capital GP IX LLC
Conversion (C): 323,916 @ $3.20 · Conversion (C): 215,146 @ $3.20 · Conversion (C): 389,078 @ $3.60 · Conversion (C): 230,753 @ $3.60 · Conversion (C): 74,613 @ $3.60 · Grant/award (A): 808,894 @ $4 · +7 moreEDGAR
2024-09-234Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 39,300 @ $0.71EDGAR
2024-09-184Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Sale (S): 63,100 @ $0.74 · Sale (S): 111,400 @ $0.73 · Sale (S): 25,631 @ $0.73EDGAR
2024-09-174MBX Biosciences, Inc. (MBX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Conversion (C): 2,658,428 · Conversion (C): 403,787 · Purchase (P): 500,000 @ $16 · Purchase (P): 250,000 @ $16 · Conversion (C): 12,372,634 (derivative) · Conversion (C): 19,587,284 (derivative) · +1 moreEDGAR
2024-08-154Keros Therapeutics, Inc. (KROS)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Sale (S): 220,600 @ $44.01 · Sale (S): 29,400 @ $44.01EDGAR
2024-07-174Terns Pharmaceuticals, Inc. (TERN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Asia GP III, L.P., OrbiMed Advisors III Ltd, OrbiMed Genesis GP LLC
Sale (S): 39,433 @ $10 · Sale (S): 5,401 @ $10 · Sale (S): 6,142 @ $10 · Sale (S): 4,009 @ $10 · Sale (S): 556 @ $10 · Sale (S): 623 @ $10EDGAR
2024-05-204Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Sale (S): 33,300 @ $22.14 · Sale (S): 1,000,000 @ $22.14EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC
Disposition to issuer (D): 1,368,339 · Disposition to issuer (D): 4,738,453 · Disposition to issuer (D): 1,368,338 · Disposition to issuer (D): 84,599 · Disposition to issuer (D): 450,000EDGAR
2024-02-144Theseus Pharmaceuticals, Inc. (THRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Code (U): 17,063,000 · Code (U): 650,600EDGAR
2023-08-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 38,327 @ $0.75 · Sale (S): 248,819 @ $0.75 · Sale (S): 535,534 @ $0.75EDGAR
2023-08-024Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 26,622 @ $3 · Sale (S): 29,700 @ $3 · Sale (S): 153,078 @ $3EDGAR
2023-07-274Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 7,800 @ $2.92 · Sale (S): 4,700 @ $2.92 · Sale (S): 26,700 @ $2.92EDGAR
2023-07-194Theseus Pharmaceuticals, Inc. (THRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 328,482 @ $3.05 · Purchase (P): 151,450 @ $3.05EDGAR
2023-07-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 9,800 @ $2.40 · Sale (S): 52,800 @ $2.40 · Sale (S): 132,100 @ $2.40EDGAR
2023-06-294Passage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Purchase (P): 617,382 @ $0.84 · Purchase (P): 575,195 @ $0.84EDGAR
2023-05-194Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Option exercise (M): 2,125 @ $4.28 · Option exercise (M): 2,125 (derivative) @ $0EDGAR
2023-05-084Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC
Purchase (P): 83,459 @ $2.75 · Purchase (P): 312,991 @ $2.75 · Purchase (P): 83,459 @ $2.75 · Purchase (P): 490,512 @ $2.82 · Purchase (P): 490,511 @ $2.82EDGAR
2023-05-024Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC
Purchase (P): 60,998 @ $2.55 · Purchase (P): 228,754 @ $2.55 · Purchase (P): 60,997 @ $2.55 · Purchase (P): 124,544 @ $2.62 · Purchase (P): 467,068 @ $2.62 · Purchase (P): 124,545 @ $2.62 · +3 moreEDGAR
2023-04-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · Sale (S): 2,091 @ $1.86 · Sale (S): 11,245 @ $1.86 · Sale (S): 28,110 @ $1.86 · +3 moreEDGAR
2023-04-124Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 2,584 @ $1.79 · Sale (S): 13,899 @ $1.79 · Sale (S): 34,745 @ $1.79 · Sale (S): 703 @ $1.82 · Sale (S): 3,784 @ $1.82 · Sale (S): 9,459 @ $1.82 · +3 moreEDGAR
2023-04-074Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Sale (S): 4,687 @ $2.18 · Sale (S): 25,220 @ $2.18 · Sale (S): 63,058 @ $2.18 · Sale (S): 487 @ $2 · Sale (S): 2,620 @ $2 · Sale (S): 6,558 @ $2EDGAR
2023-02-274Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Grant/award (A): 7,611,458 · Grant/award (A): 288,114EDGAR
2023-02-234Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC
Grant/award (A): 550,000 · Grant/award (A): 550,000EDGAR
2022-12-284Terns Pharmaceuticals, Inc. (TERN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Asia GP III, L.P., OrbiMed Advisors III Ltd, OrbiMed Genesis GP LLC
Purchase (P): 137,931 @ $7.25EDGAR
2022-11-094Theseus Pharmaceuticals, Inc. (THRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Genesis GP LLC
Purchase (P): 192,000 @ $5.21EDGAR
2022-09-214Third Harmonic Bio, Inc. (THRD)
jointly with ORBIMED ADVISORS LLC
Conversion (C): 5,479,071 · Purchase (P): 300,000 @ $17 · Conversion (C): 8,593,750 (derivative) · Conversion (C): 2,441,407 (derivative) · Conversion (C): 1,342,065 (derivative)EDGAR
2022-08-184Terns Pharmaceuticals, Inc. (TERN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Asia GP III, L.P., OrbiMed Advisors III Ltd, OrbiMed Genesis GP LLC
Purchase (P): 2,470,200 @ $2.42 · Purchase (P): 457,400 @ $2.42 · Purchase (P): 762,400 @ $2.42 · Purchase (P): 207,500 (derivative) · Purchase (P): 38,450 (derivative) · Purchase (P): 64,050 (derivative)EDGAR
2022-07-014Sierra Oncology, Inc. (SRRA)
jointly with ORBIMED ADVISORS LLC, ORBIMED CAPITAL LLC, OrbiMed Genesis GP LLC
Disposition to issuer (D): 1,511,362 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 1,136,250 (derivative) @ $0 · Disposition to issuer (D): 170,437 (derivative) @ $0 · Disposition to issuer (D): 170,437 (derivative) @ $0EDGAR
2022-06-284Arcutis Biotherapeutics, Inc. (ARQT)
jointly with ORBIMED ADVISORS LLC, ORBIMED CAPITAL LLC
Sale (S): 306,027 @ $21.31 · Sale (S): 35,944 @ $21.31EDGAR
2022-05-054/APassage BIO, Inc. (PASG)
jointly with ORBIMED ADVISORS LLC
Purchase (P): 50,800 @ $5EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs